Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Health Sciences Authority
Product Recalls

CURALIN ADVANCED GLUCOSE SUPPORT

Audiences

Healthcare professional

Industry member

Product type

Traditional medicines

5 May 2025

Consumer-level recall of CURALIN ADVANCED GLUCOSE SUPPORT due to Glibenclamide and Metformin detected.

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

Recall details

Date of Recall:

17 April 2025

Product:

CURALIN ADVANCED GLUCOSE SUPPORT

Product Category:

Traditional Medicine

Batch No.:

2023-19650 and 2023-19651

Class of Recall:

1

Level of Recall:

Consumer

Local Company:

LYC Nutrihealth (Singapore) Pte. Ltd.

Description of Issue:

The product was tested under HSA’s product quality surveillance programme and found to contain Glibenclamide and Metformin.

Recall Instructions:

Consumers:
Stop using the product immediately. Return the product to retailer or seller whom they have purchased from.
 
Retail and wholesale suppliers:
Stop supplying the affected batches and return all remaining and recalled stocks to the importer or wholesaler whom they have purchased from.

CURALIN ADVANCED GLUCOSE SUPPORT (Batch: 2023-19650, Expiry: 09/2026) 90 capsules per bottle

Curalin Advanced Glucose Support bottle front label, batch 2023-19650
Curalin Advanced Glucose Support bottle back label, batch 2023-19650


CURALIN ADVANCED GLUCOSE SUPPORT (Batch: 2023-19651, Expiry: 09/2026) 180 capsules per bottle

Curalin Advanced Glucose Support bottle front label, batch 2023-19651
Curalin Advanced Glucose Support bottle back label, batch 2023-19651

Note:

The Health Sciences Authority (HSA) publishes information regarding recalls of health products supplied in Singapore. These product recalls may be conducted on a company’s own initiative or upon HSA’s request to remove products where there are issues with quality, safety or efficacy. 

When a recall is initiated, it does not necessarily imply that a product is considered unsafe or is inefficacious. A recall can also be initiated to remove products with quality defects that does not impact safety or efficacy from the market so as to ensure that products registered in Singapore continue to meet the stringent regulatory standards stipulated by HSA.

Not all recalls will lead to press releases. However, when a recall involves a product that has been widely distributed or a product that poses a serious health risk, HSA will issue a press release to inform members of public.

Class of recall

A recall is classified as Class 1 or Class 2 depending on the potential hazard of the issue.

  • Class 1: For recalls of products with issues that can potentially cause serious adverse health outcomes or death.

  • Class 2: For recalls of products with issues that would not likely cause serious adverse health outcomes.

Level of recall

The level of product recall will depend on the potential hazard of the affected product, extent of distribution and whether other mitigating measures can be taken to address the issue.

  1. Consumer level: Affected product or batch(es) recalled from patients and consumers as well as wholesale suppliers, retail suppliers, hospitals, clinics and pharmacies.

  2. Retail level: Affected product or batch(es) recalled from retail suppliers, hospitals, clinics and pharmacies as well as wholesale suppliers.

  3. Wholesale level: Affected product or batch(es) recalled from wholesale suppliers.